On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
MondayJul 01, 2013 11:52 am

DoMark International, Inc. (DOMK) Poised to Benefit from Apple, Samsung Super Sales

DoMark International operates through wholly owned subsidiary SolaWerks to develop innovative consumer electronics products. SolaWerks’ business strategy is to acquire and develop energy-efficient technology with the potential to generate significant profit. The company designs its technology to work with Apple and Samsung devices, among others, and stands to benefit from the brands’ popularity. For the first quarter of 2013 Apple sold 37.4 million iPhones, an increase compared to iPhone sales of 35.1 million in the comparable quarter of 2012. Samsung’s flagship Galaxy smartphone sold more than 10 million units in less than a month, recording $23.6 billion in smartphone sales…

Continue Reading

MondayJul 01, 2013 11:10 am

Raptor Resources Holdings Inc. (RRHI) Releases 2nd Edition of RaptorNews

Raptor Resources Holdings today posted the 2nd edition of RaptorNews, an online publication that provides the latest company news. This issue announces that the company is forging an alliance with Steinbock Minerals Ltd. and Yasheya Ltd. via a Memorandum of Understanding. The partnerships being pursued represent the missing link to Raptor Resources’ ability to establish a strong presence in the barite marketplace as an emerging high-quality source. Partnering with these two companies will surround Raptor Resources with established industry leaders in the worldwide distribution, marketing, sales, and delivery of industrial minerals. During the due diligence period, the companies will be…

Continue Reading

MondayJul 01, 2013 9:25 am

Soligenix, Inc. (SNGX) Completes Phase 1 Study with SGX203, Treatment of Pediatric Crohn’s Disease

Soligenix, a clinical stage biopharmaceutical company developing products to treat serious gastrointestinal diseases, has enrolled and treated all 24 patients in the phase 1 Study BDP-PCD-01, the first clinical study for development of SGX203 (oral BDP) for the treatment of pediatric Crohn's disease. The objective of Study BDP-PCD-01 was to further characterize the pharmacokinetic (PK) and pharmacodynamic (PD) profile of the company's proprietary oral BDP formulation. Soligenix reports that the data was complementary to results previously obtained and confirms the safety profile observed in all previous clinical studies with oral BDP. This study enrolled subjects between the ages of 18-22.…

Continue Reading

MondayJul 01, 2013 9:14 am

Respect Your Universe, Inc. (RYUN) Announces James R. Nowodworski as CFO

Respect Your Universe announced that Mr. James R. Nowodworski has been appointed as its Chief Financial Officer, effective July 23, 2013. Mr. Nowodworski is replacing Aaron Loreth, who recently resigned as the company’s CFO. "We are lucky to have a seasoned business and financial professional of Jim's caliber join our team in a senior financial management position," noted Craig Brod, RYU’s Chief Executive Officer. "We look forward to Jim's active role in guiding the financial management of our company and our anticipated successful expansion in the retail sector. We are excited to have him on board." Mr. Nowodworski, a Certified…

Continue Reading

MondayJul 01, 2013 8:38 am

Rainbow Coral Corp. (RBCC) Partner Successfully Raises Funds for New Drug Delivery Solutions

Today before the opening bell, Rainbow Coral applauded the fundraising results achieved by joint venture partner TheraKine, Ltd. “TheraKine has done a tremendous job of bringing in outside funds to help push its innovations further into a hungry marketplace,” said RBCC CEO Patrick Brown. “The interest in TheraKine’s new drug delivery solutions is a fantastic illustration of this new system’s incredible market potential.” Rainbow Coral signed a joint venture agreement with TheraKine earlier this year to help market and develop a revolutionary, sustained-release drug delivery platform designed to make local delivery of biologic agents and small molecules safer, more effective,…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered